FOS and SUMO2

  • Number of citations of the paper that reports this interaction (PMID 16055710)
  • 44
  • Data Source:
  • HPRD (in vitro, in vivo)

FOS

SUMO2

Gene Name FBJ murine osteosarcoma viral oncogene homolog small ubiquitin-like modifier 2
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 108 interactors: ANP32E APP AQP1 ARFGAP1 ARL6IP4 ATF2 ATF3 ATF4 ATF7 ATP5I BATF BCL3 CABP1 CARM1 CEBPA CEBPE CEBPG CENPO CFAP57 CLU COPS4 CREB5 CREBBP CSNK2A1 CSNK2A2 CYTH4 DDIT3 EEF1D ELK1 ELK4 EPHB2 ETS1 ETS2 GAMT GATA4 GLB1 GNG11 GRHPR GTF2E2 GTF2F1 GTF2F2 HNF1A HSPA1A JUN JUNB JUND KDM2A LMNA LMO3 LUZP4 MAF MAFB MAFF MAP1B MAP3K7 MAPK1 MAPK7 MITF MTERF4 NACA NCOA1 NCOA2 NCOA3 NCOA6 NCOR2 NEFM NELFB NFATC3 NFKB1 OPTN PML POLR2E PRKAA2 PRKACA PSMC5 RB1 RELA RPS6KA1 RPS6KA2 RPS6KA4 RUNX1 RUNX2 SCHIP1 SET SIRT1 SMAD3 SMARCD1 SPI1 SRA1 STAT1 SUMO1 SUMO2 SUMO3 SUMO4 TAF1 TBP TRO TSC22D3 TSPAN2 UBE2D1 UBE2I UBE2L3 UBR1 USF1 USF2 VDR XBP1 ZNF133 91 interactors: ALAS1 ARL13A ARNTL ATXN1 ATXN7 AURKB BAD BCL11A BLM BRCC3 BRE C18orf25 CCNE2 CDCA8 CENPC CHAF1A CHD3 CMTM6 CORO2A CSNK2B CUL3 FAM175A FOS HDAC4 HDAC9 HIF1A HIPK2 HNF4A HOMEZ HSF2 JUN KALRN KDM1A KRT14 KRT5 KRT8 LEF1 MAF1 MAST2 MDC1 MSX1 MYB NFKBIA PARP1 PIAS1 PIAS2 PIAS3 PIAS4 PML RAC1 RANGAP1 RB1 RNF111 RNF4 SAE1 SENP1 SENP2 SENP3 SENP5 SENP6 SENP7 SETDB1 SETX SH3KBP1 SLC22A2 SNCA SOX10 SOX6 SP100 STK24 SUMO1 TDG TDP2 TEAD3 TNIP1 TOPORS TP53BP2 TRIM63 UBA2 UBE2I USP25 USPL1 VIM WRN XPC ZBTB1 ZCCHC12 ZCCHC7 ZHX1 ZMYM2 ZMYM5
Entrez ID 2353 6613
HPRD ID 01275 04332
Ensembl ID ENSG00000170345 ENSG00000188612
Uniprot IDs B4DQ65 P01100 Q6FG41 P61956
PDB IDs 1A02 1FOS 1S9K 1WM2 1WM3 1WZ0 1Z5Q 2AWT 2CKH 2D07 2IO0 2IO3 2IYD 2RPQ 3UIN 3UIO
Enriched GO Terms of Interacting Partners?
Tagcloud ?
ap  argue  capable  dimeric  dimerization  disrupt  glucocorticoid  heterodimerization  homo  homodimerization  hraralpha  hybrid  indirect  interfere  jun  liganded  occurring  promoters  protooncoproteins  ra  raralpha  rars  repress  repression  responsive  retinoic  retinoid  rxr  rxrs 
augment  consequent  delaying  elusive  emerged  enhance  enhancing  facilitates  fasting  fate  linking  maintenance  melanoma  modifications  modified  node  nutrient  partner  promising  relief  rev1  sensing  short  specialized  starvation  suppressor  therapies  toxic  turn 
Tagcloud (Difference) ?
ap  argue  capable  dimeric  dimerization  disrupt  glucocorticoid  heterodimerization  homo  homodimerization  hraralpha  hybrid  indirect  interfere  jun  liganded  occurring  promoters  protooncoproteins  ra  raralpha  rars  repress  repression  responsive  retinoic  retinoid  rxr  rxrs 
augment  consequent  delaying  elusive  emerged  enhance  enhancing  facilitates  fasting  fate  linking  maintenance  melanoma  modifications  modified  node  nutrient  partner  promising  relief  rev1  sensing  short  specialized  starvation  suppressor  therapies  toxic  turn 
Tagcloud (Intersection) ?